股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年8月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 中煙國際（香港）有限公司 | | | 呈交日期: | 2025年9月1日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06055 | | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 691,680,000 | | 0 | | 691,680,000 | | 增加 / 減少 ( ...

机构：国信证券 投资建议：上调盈利预测，维持"优于大市"评级公司是中烟体系唯一上市公司，独家经营壁垒深厚，内 生外延扩张。考虑到烟价周期高位，上调盈利预测，预计2025-2027 年归母净利润9.4/10.4/11.8亿港元 （前值9.0/9.8/10.6 亿港元），同比+9.6%/+11.4%/+12.9%；摊薄EPS=1.35/1.51/1.70 元，对应 PE=27/25/22 倍，维持"优于大市"评级。 烟叶类进口：价格驱动增长，自CBT 采购烟叶短期拖累毛利。2025H1 烟叶类进口业务收入84.0 亿港 元/+23.5%，其中烟叶进口量9.79 万吨/+2.5%、进口均价单吨8.58 万港元/+20.5%，毛利率8.2%/-2.8pct。 收入增长主要系销售单价提高，毛利下降主要系供需关系影响，自CBT 采购的烟叶成本增幅大于销售 价格增幅，短期影响业务毛利率。 烟叶类出口：量价齐升，定价优化提升盈利。2025H1 烟叶类出口业务收入11.6 亿港元/+25.9%，其中烟 叶出口量3.85 万吨/+12.7%、出口均价单吨3.00万港元/+11.7%，毛利率5.5%/+2.4pct。公司加强供需两 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 中煙國際（香港）有限公司 China Tobacco International (HK) Company Limited （ 於 香 港 註 冊 成 立 的 有 限 公 司 ） （股份代號：6055） 持續關連交易 釐定年度上限 境外銷售煙葉類產品框架協議 於2025年8月29日，本公司與相關買方訂立境外銷售煙葉類產品框架協議，內容有關本 集團向中國煙草總公司旗下相關境外實體銷售煙葉類產品，作為煙葉類產品出口業務 的一部分。 各買方均為中國煙草總公司的附屬公司或聯營公司。中國煙草總公司通過其直接全資 附屬公司中煙國際集團，於本公告日期持有本公司已發行股本總額約72.29%，並為本公 司的最終控股股東。因此，各買方因屬中國煙草總公司的聯繫人，根據上市規則定義， 均為本公司的關連人士。 由於根據上市規則計算的適用百分比率，就境外銷售煙葉類產品框架協議項下擬進行 的銷售交易之最高年度上限超過0.1%但均少於 ...

FDA授权销售20种ZYN尼古丁口含袋产品 智通财经APP获悉，天风证券发布研报称，根据欧睿国际数据显示(数据为尼古丁袋口含烟数据)，2024 年全球口含烟市场规模为112.32亿美元，同比+57.57%，预计2028年达到251.48亿美元，2024- 2028CAGR为22.32%。北美、欧洲口含烟市场目前增速依然保持较高水平，目前仍有较大的市场空间； 亚洲和非洲口含烟市场目前处于早期阶段，随着口含烟市场的进一步发展，新兴市场的市场潜力有望快 速兑现。此外，FDA对于口含烟水果味的审批，有望成为口含烟市场的催化剂，进一步提升市场的增 速，抬高整个市场的空间上限。 天风证券主要观点如下： 口含烟零售市场集中度高，菲莫国际、英美烟草、奥驰亚口含烟业务表现亮眼 根据欧睿国际数据显示(数据为尼古丁袋口含烟数据)，2024年全球口含烟市场规模为112.32亿美元，同 比+57.57%，预计2028年达到251.48亿美元，2024-2028CAGR为22.32%，其中北美市场2024年口含烟市 场规模为87.75亿美元，同比+58.30%，预计2028年达到194.49亿美元，2024-2028CAGR为22.01 ...

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The revenue growth was primarily driven by the import and export of tobacco leaf products and cigarette exports, while the net profit increase was attributed to improved profitability in cigarette and tobacco leaf exports, alongside a significant reduction in financing costs by 28% [1] - The company plans to distribute an interim dividend of HKD 0.19 per share, representing a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with an export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue increased by 0.8% to HKD 550 million, with an export volume of 1.019 billion sticks (-7.9%) and an average export price of HKD 0.54 per stick (+9.4%). The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with an export volume of 81 million sticks (-65.4%) and an average export price of HKD 0.18 per stick (-3.0%). The gross margin remained at 5.5% [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with an export volume of 7,900 tons (-34.8%) and an average export price of HKD 24,600 per ton (-23.8%). The gross margin improved to 27.4% [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding PE ratios of 27, 25, and 22 times [1][4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The growth in revenue is primarily driven by the import and export of tobacco leaf products, as well as cigarette exports, while the net profit growth is attributed to improved profitability in cigarette and tobacco leaf exports and a significant reduction in financing costs by 28% [1][2] - The company plans to distribute an interim dividend of HKD 0.19 per share, representing a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue increased by 0.8% to HKD 550 million, with export volume declining by 7.9% to 1.019 billion sticks, while the average export price rose by 9.4% to HKD 0.54 per stick. The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with export volume down by 65.4% to 81 million sticks, primarily due to geopolitical conflicts and regulatory changes [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with export volume down by 34.8% to 7,900 tons, affected by extreme weather and product mix changes [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding P/E ratios of 27, 25, and 22 [1][4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The growth in revenue is primarily driven by the import and export of tobacco leaf products and cigarette exports, while the net profit increase is attributed to improved profitability in cigarette and tobacco leaf exports, alongside a significant reduction in financing costs by 28% [1][2] - The company plans to distribute an interim dividend of HKD 0.19 per share, reflecting a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue slightly increased by 0.8% to HKD 550 million, with export volume declining by 7.9% to 1.019 billion sticks, while the average export price rose by 9.4% to HKD 0.54 per stick. The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with export volume down by 65.4% to 81 million sticks, primarily due to geopolitical conflicts and regulatory changes [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with export volume down by 34.8% to 7,900 tons, affected by extreme weather and product mix changes [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding P/E ratios of 27, 25, and 22 [1][4]

制作：产品中心 《策略|"十五五"前瞻初探——"十五五"研究系列》 1、"十五五"规划展望。自 1953 年开始制定第一个"五年计划"以来， 我国已发布十四个"五年规划"。完善统一大市场：推进统一大市场建设 重点在于打破地方保护和市场分割，促进资源的高效配置流动，激发各类 市场主体活力与创造力。2、促进民生消费："十五五"规划可能在以下几 方面进一步对消费进行支持：1.财政支出从投资进一步转向民生；2.大力 支持消费结构升级。3、深化国有企业改革：整体来看，预计"十五五" 中，国有企业改革整体思路或依旧延续精细化区分、"一企一策"的思路， 同时要积极探索尝试有利于创新的国有企业经营机制和公司治理模式。4、 健全资本市场稳定机制："十五五"期间资本市场改革思路或转向"构建 内在稳定、韧性强的现代化资本市场生态系统"。整体来看，"十五五"期 间的资本市场稳定机制建设将是一个系统性的工程，完成从"政策驱动" 到"制度驱动"、从"单一维度"到"生态系统"的转型，推动资本市场 高质量发展,助力加快建设金融强国。 证券研究报告 | 2025 年 08 月 27 日 $$\overline{{{\prod_{\mathrm ...

2. 公司经营模式优势凸显，稀缺性较强 稀缺优势：中烟香港拥有相关烟草国际业务独家经营权。根据中国烟草总公司60号文，中烟香港是中国 烟草总公司指定的从事国际业务拓展平台及相关贸易业务的独家营运实体。我们认为该"独家地位"较为 罕见，未来或将持续受益于中烟进行海外拓展及股权并购整合事宜。 机构：天风证券 研究员：吴立 事件：公司发布2025 年中报，2025 年上半年公司实现收103.16 亿港元，同比+18.5%；实现归属于公司 权益持有人的净利润7.06 亿港元，同比+9.8%；同时派发每股0.19 港元的中期股息，同比+26.7%。 1. 烟叶进出口业务受益于烟叶价格上涨，卷烟业务自营比例持续提升烟叶类出口业务：2025H1 实现收 入11.56 亿港元，同比+25.9%，营收占比为11.2%，毛利率为5.5%，同比+2.4pct，主要受益于公司积极 拓展新市场新客户，烟叶类产品出口数量增长，同时持续优化定价策略，实现烟叶类产品整体销售单价 与毛利水平大幅增长。 烟叶类进口业务：2025H1 实现收入83.99 亿港元，同比+23.5%，该板块营收占比为81.4%，毛利率为 8.2%，同比-2.8pct ...

烟叶进出口营收快增，卷烟出口、新型烟草及巴西业务短期承压。1H25具体看，1）烟叶进口：收入同 增23.5%，其中进口量/均价同增2.5%/20.5%，发运节奏影响下均价较高烟叶占比提升；2）烟叶出口： 收入同增25.9%，其中出口量/均价同增12.7%/11.7%，公司积极拓展新客户，产品结构优化带动均价提 升；3）卷烟出口：收入同增0.8%，销量/均价同比-7.9%/+9.4%，发运节奏影响下销量短期承压，产品 结构优化带动均价提升；4）新型烟草：收入同降66.4%，销量/均价同降65.4%/3.1%，供应链及海外监 管波动下经营承压；5）巴西业务：收入同降50.3%，销量/均价同降34.8%/23.8%，气候制约、副产品出 货节奏影响收入增速；烟叶出口、卷烟出口及巴西业务毛利率向好，气候影响烟叶进口盈利水平。 1H25 公司毛利率实现9.2%，同降1.9ppt，其中定价策略优化下烟叶出口毛利率同增2.4ppt，自营比例提 升下卷烟出口毛利率同增3.5ppt，副产品收入占比提升带动巴西业务毛利率同增10.2ppt，但气候不利影 响下公司于巴西进口烟叶成本上升，烟叶进口毛利率同降2.8ppt。费用端，1H2 ...